Nadia Altomare

Direktor/Vorstandsmitglied bei Savran Technologies, Inc.

Vermögen: 189 222 $ am 30.04.2024

54 Jahre

Health Technology

Consumer Services

Health Services

Aktive Positionen von Nadia Altomare

Unternehmen	Position	Beginn	Ende
Savran Technologies, Inc. Savran Technologies, Inc. BiotechnologyHealth Technology Savran Technologies, Inc. provide and develops a technology to isolate ultra-rare cells from blood. The company was founded by Cagri Savran in 2018 and is headquartered in Cambridge, MA.	Direktor/Vorstandsmitglied	-	-
Patient Rights Advocate, Inc.	Direktor/Vorstandsmitglied	-	-

Unternehmen	Position	Beginn	Ende
SERA PROGNOSTICS, INC.	Corporate Officer/Principal	01.05.2017	09.06.2023
Abcodia Ltd. Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom.	Direktor/Vorstandsmitglied	25.05.2015	01.05.2017
	Vorstandsvorsitzender	11.01.2016	01.05.2017
	Präsident	25.05.2015	11.01.2016
THERMO FISHER SCIENTIFIC	Corporate Officer/Principal	01.01.2012	01.01.2014
REVVITY, INC.	Corporate Officer/Principal	01.01.2011	01.01.2012

Stony Brook University	Undergraduate Degree
Northeastern University	Masters Business Admin

International

Vereinigte Staaten	8
Vereinigtes Königreich	2

Operativ

Director/Board Member	3
Corporate Officer/Principal	3
Chief Executive Officer	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
REVVITY, INC.	Health Technology
THERMO FISHER SCIENTIFIC	Health Technology
SERA PROGNOSTICS, INC.	Health Services

Private Unternehmen	3
Abcodia Ltd. Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom.	Health Technology
Savran Technologies, Inc. Savran Technologies, Inc. BiotechnologyHealth Technology Savran Technologies, Inc. provide and develops a technology to isolate ultra-rare cells from blood. The company was founded by Cagri Savran in 2018 and is headquartered in Cambridge, MA.	Health Technology
Patient Rights Advocate, Inc.